{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T23:07:51Z","timestamp":1773097671208,"version":"3.50.1"},"reference-count":86,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T00:00:00Z","timestamp":1564704000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Behav. Neurosci."],"DOI":"10.3389\/fnbeh.2019.00176","type":"journal-article","created":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T12:03:55Z","timestamp":1564747435000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Selegiline Recovers Synaptic Plasticity in the Medial Prefrontal Cortex and Improves Corresponding Depression-Like Behavior in a Mouse Model of Parkinson\u2019s Disease"],"prefix":"10.3389","volume":"13","author":[{"given":"Motoki","family":"Okano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazue","family":"Takahata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junya","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shizuko","family":"Muraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2019,8,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/sj.bjp.0705962","article-title":"Cardiovascular activity of rasagiline, a selective and potent inhibitor of mitochondrial monoamine oxidase B: comparison with selegiline.","volume":"143","author":"Abassi","year":"2004","journal-title":"Br. J. Pharmacol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.physbeh.2016.04.052","article-title":"Involvement of D1 and D2 dopamine receptors in the antidepressant-like effects of selegiline in maternal separation model of mouse.","volume":"163","author":"Amiri","year":"2016","journal-title":"Physiol. Behav."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/513452","article-title":"Dopaminergic modulation of medial prefrontal cortex deactivation in Parkinson depression.","volume":"2015","author":"Andersen","year":"2015","journal-title":"Parkinsons Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1038\/nn2054","article-title":"CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking.","volume":"11","author":"Anderson","year":"2008","journal-title":"Nat. Neurosci."},{"key":"B5","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1111\/ene.12757","article-title":"Effects of rotigotine transdermal patch in patients with Parkinson\u2019s disease presenting with non-motor symptoms - results of a double-blind, randomized, placebo-controlled trial.","volume":"22","author":"Antonini","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B6","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S0091-3057(01)00599-8","article-title":"Intra- and interstrain differences in models of \u201cbehavioral despair\u201d.","volume":"70","author":"Bai","year":"2001","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1002\/mds.22643","article-title":"The PRIAMO study: a multicenter assessment of nonmotor symptoms and their impact on quality of life in Parkinson\u2019s disease.","volume":"24","author":"Barone","year":"2009","journal-title":"Mov. Disord."},{"key":"B8","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S1474-4422(10)70106-X","article-title":"Pramipexole for the treatment of depressive symptoms in patients with Parkinson\u2019s disease: a randomised, double-blind, placebo-controlled trial.","volume":"9","author":"Barone","year":"2010","journal-title":"Lancet Neurol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1111\/ene.12724","article-title":"A randomized clinical trial to evaluate the effects of rasagiline on depressive symptoms in non-demented Parkinson\u2019s disease patients.","volume":"22","author":"Barone","year":"2015","journal-title":"Eur. J. Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.bbr.2014.06.029","article-title":"Pramipexole but not imipramine or fluoxetine reverses the \u201cdepressive-like\u201d behaviour in a rat model of preclinical stages of Parkinson\u2019s disease.","volume":"271","author":"Berghauzen-Maciejewska","year":"2014","journal-title":"Behav. Brain Res."},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2014.00290","article-title":"A mouse model of non-motor symptoms in Parkinson\u2019s disease: focus on pharmacological interventions targeting affective dysfunctions.","volume":"8","author":"Bonito-Oliva","year":"","journal-title":"Front. Behav. Neurosci."},{"key":"B12","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.biopsych","article-title":"Cognitive impairment and dentate gyrus synaptic dysfunction in experimental parkinsonism.","volume":"75","author":"Bonito-Oliva","year":"","journal-title":"Biol. Psychiatry"},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease.","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"key":"B14","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/brain\/awn340","article-title":"Synaptic plasticity, dopamine and Parkinson\u2019s disease: one step ahead.","volume":"132","author":"Calabresi","year":"2009","journal-title":"Brain"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3791\/3769","article-title":"The tail suspension test.","volume":"59","author":"Can","year":"2012","journal-title":"J. Vis. Exp."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/srep44426","article-title":"Pramipexole restores depressed transmission in the ventral hippocampus following MPTP-lesion.","volume":"7","author":"Castro-Hern\u00e1ndez","year":"2017","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1016\/j.neuron.2017.04.041","article-title":"CaMKII autophosphorylation is necessary for optimal integration of Ca2+ signals during LTP induction, but not maintenance.","volume":"94","author":"Chang","year":"2017","journal-title":"Neuron"},{"key":"B18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.euroneuro.2006.04.006","article-title":"Effect of antidepressant drugs on 6-OHDA-treated mice in the FST.","volume":"17","author":"Chenu","year":"2007","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1884","DOI":"10.1093\/brain\/aws101","article-title":"Mechanisms underlying the impairment of hippocampal long-term potentiation and memory in experimental Parkinson\u2019s disease.","volume":"135","author":"Costa","year":"2012","journal-title":"Brain"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.3791\/2609","article-title":"Measuring motor coordination in mice.","volume":"75","author":"Deacon","year":"2013","journal-title":"J. Vis. Exp."},{"key":"B21","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1002\/mds.21966","article-title":"Comparison of desipramine and citalopram treatments for depression in Parkinson\u2019s disease: a double-blind, randomized, placebo-controlled study.","volume":"23","author":"Devos","year":"2008","journal-title":"Mov. Disord."},{"key":"B22","doi-asserted-by":"publisher","first-page":"11750","DOI":"10.1523\/JNEUROSCI.0234-12.2012","article-title":"Extracellular alpha-synuclein oligomers modulate synaptic transmission and impair LTP via NMDA-receptor activation.","volume":"32","author":"Di\u00f3genes","year":"2012","journal-title":"J. Neurosci."},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0106561","article-title":"Does anxiety cause freezing of gait in Parkinson\u2019s disease?","volume":"9","author":"Ehgoetz Martens","year":"2014","journal-title":"PLoS One"},{"key":"B24","doi-asserted-by":"publisher","first-page":"2028","DOI":"10.1111\/ejn.12928","article-title":"Anxiety-provoked gait changes are selectively dopa-responsive in Parkinson\u2019s disease.","volume":"42","author":"Ehgoetz Martens","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"B25","author":"Franklin","year":"2008","journal-title":"The Mouse Brain in Stereotaxic Coordinates."},{"key":"B26","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1002\/mds.26513","article-title":"Dementia in Parkinson\u2019s disease is associated with enhanced mitochondrial complex I deficiency.","volume":"31","author":"Gatt","year":"2016","journal-title":"Mov. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"870","DOI":"10.1126\/science.279.5352.870","article-title":"Autophosphorylation at Thr286 of the \u03b1 calcium-calmodulin kinase II in LTP and learning.","volume":"279","author":"Giese","year":"1998","journal-title":"Science"},{"key":"B28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1002\/mds.24938","article-title":"Entorhinal cortex atrophy differentiates Parkinson\u2019s disease patients with and without dementia.","volume":"27","author":"Goldman","year":"2012","journal-title":"Mov. Disord."},{"key":"B29","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.biopsych.2009.08.026","article-title":"Functional and dysfunctional synaptic plasticity in prefrontal cortex: roles in psychiatric disorders.","volume":"67","author":"Goto","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2018.00608","article-title":"Structural brain network alteration and its correlation with structural impairments in patients with depression in de novo and drug-na\u00efve Parkinson\u2019s disease.","volume":"9","author":"Gou","year":"2018","journal-title":"Front. Neurol."},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2017.00084","article-title":"Reduced CA2-CA3 hippocampal subfield volume is related to depression and normalized by L-DOPA in newly diagnosed Parkinson\u2019s disease.","volume":"8","author":"Gy\u00f6rfi","year":"2017","journal-title":"Front. Neurol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.1002\/mds.23738","article-title":"The effects of rasagiline on cognitive deficits in Parkinson\u2019s disease patients without dementia: a randomized, double-blind, placebo-controlled, multicenter study.","volume":"26","author":"Hanagasi","year":"2011","journal-title":"Mov. Disord."},{"key":"B33","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/j.neurol.2016.10.002","article-title":"Combination of paroxetine and rasagiline induces serotonin syndrome in a parkinsonian patient.","volume":"172","author":"H\u00e9bant","year":"2016","journal-title":"Rev. Neurol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1254\/jphs.12023FP","article-title":"Possible modulation of the amygdala on metaplasticity deficits in the hippocampal CA1 field in early postnatally stressed rats.","volume":"119","author":"Hiraide","year":"2012","journal-title":"J. Pharmacol. Sci."},{"key":"B35","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.neuroscience.2011.02.015","article-title":"BL-1023 improves behavior and neuronal survival in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-intoxicated mice.","volume":"180","author":"Hutter-Saunders","year":"2011","journal-title":"Neuroscience"},{"key":"B36","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.bbr.2018.10.032","article-title":"Selegiline ameliorates depression-like behaviors in rodents and modulates hippocampal dopaminergic transmission and synaptic plasticity.","volume":"359","author":"Ishikawa","year":"2019","journal-title":"Behav. Brain Res."},{"key":"B37","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/00001756-200105080-00028","article-title":"Mouse hippocampo-prefrontal paired-pulse facilitation and long-term potentiation in vivo.","volume":"12","author":"Izaki","year":"2001","journal-title":"Neuroreport"},{"key":"B38","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1016\/0306-4522(90)90389-L","article-title":"Decreased tyrosine hydroxylase messenger RNA in the surviving dopamine neurons of the substantia nigra in Parkinson\u2019s disease: an in situ hybridization study.","volume":"38","author":"Javoy-Agid","year":"1990","journal-title":"Neuroscience"},{"key":"B39","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JPD-140424","article-title":"Acute effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) or paraquat on core temperature in C57BL\/6J Mice.","volume":"5","author":"Jiao","year":"2015","journal-title":"J. Parkinsons Dis."},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2017.00075","article-title":"Selegiline ameliorates depression-like behavior in mice lacking the CD157\/BST1 gene, a risk factor for Parkinson\u2019s disease.","volume":"11","author":"Kasai","year":"2017","journal-title":"Front. Behav. Neurosci."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1038\/npp.2015.310","article-title":"State-dependent partial occlusion of cortical LTP-like plasticity in major depression.","volume":"41","author":"Kuhn","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"B42","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1038\/sj.bjp.0702389","article-title":"Effect of low-dose treatment with selegiline on dopamine transporter (DAT) expression and amphetamine-induced dopamine release in vivo.","volume":"126","author":"Lamensdorf","year":"1999","journal-title":"Br. J. Pharmacol."},{"key":"B43","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1056\/NEJM199810083391506","article-title":"Parkinson\u2019s disease. First of two parts.","volume":"339","author":"Lang","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"B44","doi-asserted-by":"publisher","first-page":"92","DOI":"10.14802\/jmd.15003","article-title":"Many faces of Parkinson\u2019s disease: non-motor symptoms of Parkinson\u2019s disease.","volume":"8","author":"Lee","year":"2015","journal-title":"J. Mov. Disord."},{"key":"B45","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/nrn3192","article-title":"Mechanisms of CaMKII action in long-term potentiation.","volume":"13","author":"Lisman","year":"2012","journal-title":"Nat. Rev. Neurosci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1007\/BF00177912","article-title":"The use of a plus-maze to measure anxiety in the mouse.","volume":"92","author":"Lister","year":"1987","journal-title":"Psychopharmacology"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1038\/srep15720","article-title":"Tiagabine protects dopaminergic neurons against neurotoxins by inhibiting microglial activation.","volume":"5","author":"Liu","year":"2016","journal-title":"Sci. Rep."},{"key":"B48","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1016\/j.neuron.2008.12.015","article-title":"Activity-dependent modulation of limbic dopamine D3 receptors by CaMKII.","volume":"61","author":"Liu","year":"2009","journal-title":"Neuron"},{"key":"B49","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1001\/archpsyc.1989.01810010047007","article-title":"A controlled study of the antidepressant efficacy and side effects of (\u2212)-deprenyl: a selective monoamine oxidase inhibitor.","volume":"46","author":"Mann","year":"1989","journal-title":"Arch. Gen. Psychiatry"},{"key":"B50","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1212\/01.wnl.0000336340.89821.b3","article-title":"A controlled trial of antidepressants in patients with Parkinson disease and depression.","volume":"72","author":"Menza","year":"2009","journal-title":"Neurology"},{"key":"B51","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1016\/j.neures.2004.11.008","article-title":"Neural mechanisms underlying motor dysfunction as detected by the tail suspension test in MPTP-treated C57BL\/6 mice.","volume":"51","author":"Mori","year":"2005","journal-title":"Neurosci. Res."},{"key":"B52","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1111\/j.1471-4159.2011.07608.x","article-title":"Reduced calcium\/calmodulin-dependent protein kinase II activity in the hippocampus is associated with impaired cognitive function in MPTP-treated mice.","volume":"120","author":"Moriguchi","year":"2012","journal-title":"J. Neurochem."},{"key":"B53","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1586\/ern.13.60","article-title":"Revelation in the neuroprotective functions of rasagiline and selegiline: the induction of distinct genes by different mechanisms.","volume":"13","author":"Naoi","year":"2013","journal-title":"Expert Rev Neurother."},{"key":"B54","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1002\/mds.22760","article-title":"Anxious and depressive symptoms in Parkinson\u2019s disease: the French cross-sectionnal DoPaMiP study.","volume":"25","author":"N\u00e8gre-Pag\u00e8s","year":"2010","journal-title":"Mov. Disord."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0064723","article-title":"Adult bone marrow neural crest stem cells and mesenchymal stem cells are not able to replace lost neurons in acute MPTP-lesioned mice.","volume":"8","author":"Neirinckx","year":"2013","journal-title":"PLoS One"},{"key":"B56","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.biopsych.2006.10.006","article-title":"Long-term plasticity of visually evoked potentials in humans is altered in major depression.","volume":"62","author":"Normann","year":"2007","journal-title":"Biol. Psychiatry"},{"key":"B57","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Antidepressant effect of pramipexole in mice forced swimming test: a cross talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway.","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"B58","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1093\/cercor\/bhp108","article-title":"Identification of the hippocampal input to medial prefrontal cortex in vitro.","volume":"20","author":"Parent","year":"2010","journal-title":"Cereb. Cortex"},{"key":"B59","doi-asserted-by":"publisher","first-page":"5291","DOI":"10.1523\/JNEUROSCI.1069-07.2007","article-title":"Effects of treadmill exercise on dopaminergic transmission in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned mouse model of basal ganglia injury.","volume":"27","author":"Petzinger","year":"2007","journal-title":"J. Neurosci."},{"key":"B60","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1073\/pnas.0604049104","article-title":"D1-D2 dopamine receptor heterooligomers with unique pharmacology are coupled to rapid activation of Gq\/11 in the striatum.","volume":"104","author":"Rashid","year":"2007","journal-title":"Proc. Natl Acad. Sci. U.S.A."},{"key":"B61","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1212\/WNL.48.4.1070","article-title":"Serotonin syndrome and the combined use of deprenyl and an antidepressant in Parkinson\u2019s disease.","volume":"48","author":"Richard","year":"1997","journal-title":"Neurology"},{"key":"B62","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1093\/cercor\/bhg122","article-title":"Acute stress-induced changes in hippocampal\/prefrontal circuits in rats: effects of antidepressants.","volume":"14","author":"Rocher","year":"2004","journal-title":"Cereb. Cortex"},{"key":"B63","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1111\/j.1460-9568.2008.06314.x","article-title":"EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress.","volume":"28","author":"Rojas","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"B64","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/S0969-9961(03)00108-6","article-title":"Behavioral changes are not directly related to striatal monoamine levels, number of nigral neurons, or dose of parkinsonian toxin MPTP in mice.","volume":"14","author":"Rousselet","year":"2003","journal-title":"Neurobiol. Dis"},{"key":"B65","doi-asserted-by":"publisher","first-page":"S41","DOI":"10.1016\/j.parkreldis.2015.09.027","article-title":"Non motor subtypes and Parkinson\u2019s disease.","volume":"22","author":"Sauerbier","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2011.12.014","article-title":"Pramipexole is active in depression tests and modulates monoaminergic transmission, but not brain levels of BDNF in mice.","volume":"677","author":"Schulte-Herbr\u00fcggen","year":"2012","journal-title":"Eur. J. Pharmacol."},{"key":"B67","doi-asserted-by":"publisher","first-page":"S42","DOI":"10.1002\/mds.23884","article-title":"The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson\u2019s disease.","volume":"26","author":"Seppi","year":"2011","journal-title":"Mov. Disord."},{"key":"B68","doi-asserted-by":"publisher","first-page":"563","DOI":"10.1016\/j.euroneuro.2005.02.003","article-title":"Antidepressant-like effects of selegiline in the forced swim test.","volume":"15","author":"Shimazu","year":"2005","journal-title":"Eur. Neuropsychopharmacol."},{"key":"B69","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.brainres.2014.04.015","article-title":"Effects of gypenosides on anxiety disorders in MPTP-lesioned mouse model of Parkinson\u2019s disease.","volume":"1567","author":"Shin","year":"2014","journal-title":"Brain Res."},{"key":"B70","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1007\/s00213-004-1809-7","article-title":"The activity of pramipexole in the mouse forced swim test is mediated by D2 rather than D3 receptors.","volume":"175","author":"Siuciak","year":"2004","journal-title":"Psychopharmacology"},{"key":"B71","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1001\/jamaneurol.2014.2472","article-title":"Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.","volume":"72","year":"2015","journal-title":"JAMA Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/BF00428203","article-title":"The tail suspension test: a new method for screening antidepressants in mice.","volume":"85","author":"Steru","year":"1985","journal-title":"Psychopharmacology"},{"key":"B73","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1101\/lm.63806","article-title":"Dopamine transporter blockade increases LTP in the CA1 region of the rat hippocampus via activation of the D3 dopamine receptor.","volume":"13","author":"Swant","year":"2006","journal-title":"Learn. Mem."},{"key":"B74","doi-asserted-by":"publisher","first-page":"12032","DOI":"10.1523\/JNEUROSCI.3446-08.2008","article-title":"Differential contributions of prefrontal and hippocampal dopamine D(1) and D(2) receptors in human cognitive functions.","volume":"28","author":"Takahashi","year":"2008","journal-title":"J. Neurosci."},{"key":"B75","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/mds.23429","article-title":"Systematic review of levodopa dose equivalency reporting in Parkinson\u2019s disease.","volume":"25","author":"Tomlinson","year":"2010","journal-title":"Mov. Disord."},{"key":"B76","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0079510","article-title":"A meta-analysis of randomised placebo-controlled treatment trials for depression and anxiety in Parkinson\u2019s disease.","volume":"8","author":"Troeung","year":"2013","journal-title":"PLoS One"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2013.00128","article-title":"Motor cortical plasticity in Parkinson\u2019s disease.","volume":"4","author":"Udupa","year":"2013","journal-title":"Front. Neurol."},{"key":"B78","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1046\/j.1365-2125.2001.01491.x","article-title":"Start of a selective serotonin reuptake inhibitor (SSRI) and increase of antiparkinsonian drug treatment in patients on levodopa.","volume":"54","author":"van de Vijver","year":"2002","journal-title":"Br. J. Clin. Pharmacol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1002\/mds.26112","article-title":"Depressive symptoms in Parkinson\u2019s disease are related to decreased hippocampus and amygdala volume.","volume":"30","author":"van Mierlo","year":"2015","journal-title":"Mov. Disord."},{"key":"B80","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.parkreldis.2015.12.001","article-title":"Depression and anxiety are co-morbid but dissociable in mild Parkinson\u2019s disease: a prospective longitudinal study of patterns and predictors.","volume":"23","author":"Wee","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"B81","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.pbb.2013.10.022","article-title":"Antidepressant-like activity of the adenosine A(2A) receptor antagonist, istradefylline (KW-6002), in the forced swim test and the tail suspension test in rodents.","volume":"11","author":"Yamada","year":"2013","journal-title":"Pharmacol. Biochem. Behav."},{"key":"B82","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.3906\/sag-1408-68","article-title":"Impaired cognitive performance and hippocampal atrophy in Parkinson disease.","volume":"45","author":"Yildiz","year":"2015","journal-title":"Turk. J. Med. Sci."},{"key":"B83","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/sj.bjp.0703826","article-title":"Rasagiline [N-propargyl-1R(+)-aminoindan], a selective and potent inhibitor of mitochondrial monoamine oxidase B.","volume":"132","author":"Youdim","year":"2001","journal-title":"Br. J. Pharmacol."},{"key":"B84","doi-asserted-by":"publisher","DOI":"10.1038\/srep06811","article-title":"Interactions of CaMKII with dopamine D2 receptors: roles in levodopa-induced dyskinesia in 6-hydroxydopamine lesioned Parkinson\u2019s rats.","volume":"4","author":"Zhang","year":"2014","journal-title":"Sci. Rep."},{"key":"B85","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2016.00101","article-title":"MPTP impairs dopamine D1 receptor-mediated survival of newborn neurons in ventral hippocampus to cause depressive-like behaviors in adult mice.","volume":"9","author":"Zhang","year":"2016","journal-title":"Front. Mol Neurosci."},{"key":"B86","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1038\/nrneurol.2013.57","article-title":"The role of neuroplasticity in dopaminergic therapy for Parkinson disease.","volume":"9","author":"Zhuang","year":"2013","journal-title":"Nat. Rev. Neurol."}],"container-title":["Frontiers in Behavioral Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnbeh.2019.00176\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,2]],"date-time":"2019-08-02T12:03:58Z","timestamp":1564747438000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fnbeh.2019.00176\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,2]]},"references-count":86,"alternative-id":["10.3389\/fnbeh.2019.00176"],"URL":"https:\/\/doi.org\/10.3389\/fnbeh.2019.00176","relation":{},"ISSN":["1662-5153"],"issn-type":[{"value":"1662-5153","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,8,2]]},"article-number":"176"}}